Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.73 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.73 |
| ▸ | ARG1 | P05089 | 1/20 | 0.42 |
| ▸ | ARG2 | P78540 | 1/20 | 0.42 |
| ▸ | NOS2 | P35228 | 3/20 | 0.42 |
| ▸ | NOS1 | P29475 | 2/20 | 0.42 |
| ▸ | NOS3 | P29474 | 1/20 | 0.42 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.40 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 2/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cystine SCHEMBL457217 | 1.00 | PTGS1 (0.73) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL457219 | 1.00 | PTGS1 (0.73) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL27673473 | 0.92 | PTGS1 (0.61) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cysteine SCHEMBL3416421 | 0.90 | PTGS1 (0.64) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL15667872 | 0.90 | PTGS1 (0.58) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL1983072 | 0.88 | PTGS1 (0.52) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL27890268 | 0.88 | PTGS1 (0.52) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL7442337 | 0.88 | PTGS1 (0.52) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL5018669 | 0.88 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL8332360 | 0.88 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112964682-B | Method for visually and quantitatively marking aggregated functional protein in cells | 中国科学院高能物理研究所 | 2022-02-25 | — | — | CN | claimed |
| CN-112964682-A | Method for visually and quantitatively marking aggregated functional protein in cells | 中国科学院高能物理研究所 | 2021-06-15 | — | — | CN | claimed |
| CN-107375993-A | A kind of preparation method of copper silver nanoclusters composite aquogel | 重庆科技学院 | 2017-11-24 | — | — | CN | claimed |
| CN-103313990-B | Alanyl maytansinol antibody coupling matter | 基因泰克公司 | 2016-07-20 | — | — | CN | claimed |
| US-12022829-B2 | Water-dispersible fine particle | TOYOBO CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| WO-2023083361-A1 | NEW METHOD FOR IMPROVING QUALITY OF PLATELETS | 上海循曜生物科技有限公司 | 2023-05-19 | — | — | WO | disclosed |
| WO-2023069598-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023288301-A1 | ENGINEERED BIOMOLECULES FOR NUTRIENT REPROGRAMMING | CORNELL UNIVERSITY (US) | 2023-01-19 | — | — | WO | disclosed |
| CN-115160245-A | Non-natural chiral amino acid containing tetrazole functional group, and preparation method and application thereof | 天津大学 | 2022-10-11 | — | — | CN | disclosed |
| CN-112964682-B | Method for visually and quantitatively marking aggregated functional protein in cells | 中国科学院高能物理研究所 | 2022-02-25 | — | — | CN | disclosed |
| US-20220030861-A1 | WATER-DISPERSIBLE FINE PARTICLE | TOYOBO CO., LTD. (JP) | 2022-02-03 | — | — | US | disclosed |
| CN-114008452-A | Method for evaluating food related to cognitive function | 味之素株式会社 | 2022-02-01 | — | — | CN | disclosed |
| WO-1999040888-A1 | COMPOSITIONS AND METHODS OF TREATING KERATIN-RELATED DISORDERS AND CONDITIONS | BUCK CAROL J (US) | 1999-08-19 | — | — | WO | disclosed |
| EP-0787228-A4 | CHEMICALLY ASSISTED PROTEIN ANNEALING TREATMENT | COMMW SCIENT IND RES ORG (AU) | 1998-09-02 | — | — | EP | disclosed |
| CN-1161067-A | Chemically accelerated protein heat treatment | COMMW SCIENT IND RES ORG (AU) | 1997-10-01 | — | — | CN | disclosed |
| EP-0787228-A1 | CHEMICALLY ASSISTED PROTEIN ANNEALING TREATMENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996012057-A1 | CHEMICALLY ASSISTED PROTEIN ANNEALING TREATMENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1996-04-25 | — | — | WO | disclosed |
| EP-0608217-A1 | SOLUBLE AND STABLE SOURCES OF TYROSINE, CYSTEINE AND GLUTAMINE FOR TOTAL PARENTERAL NUTRITION | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1994-08-03 | — | — | EP | disclosed |
| EP-0608217-A4 | SOLUBLE AND STABLE SOURCES OF TYROSINE, CYSTEINE AND GLUTAMINE FOR TOTAL PARENTERAL NUTRITION. | RES CORP TECHNOLOGIES INC (US) | 1993-12-06 | — | — | EP | disclosed |
| WO-1991016067-A1 | SOLUBLE AND STABLE SOURCES OF TYROSINE, CYSTEINE AND GLUTAMINE FOR TOTAL PARENTERAL NUTRITION | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12022829-B2 | Water-dispersible fine particle | ABCG2, FIBP, MMP1 | PTGS1 1898/4885SLC7A11 591/4885ARG1 495/4885 |
| US-20220030861-A1 | WATER-DISPERSIBLE FINE PARTICLE | ABCG2, FIBP, MMP1 | PTGS1 1898/4885SLC7A11 591/4885ARG1 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.